基于聚合物的基因药物联合递送系统通过双重抗炎和抗血管作用有效抑制病态视网膜新血管化
Mengtian He1, Dayang Xie2, Qiannan Cao2
1Department of Ophthalmology, The Second Hospital of Jilin University, Changchun 130041, China.
Biomaterials
|September 8, 2025
概括
一种新的基因药物递送系统,DPPV,通过结合抗血管生成和抗炎症,有效地抑制视网膜新血管化,为心底神经血管疾病提供有希望的治疗方法,并减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
背景情况:
- 视网膜新血管化会导致视力丧失和失明.
- 目前的抗VEGF治疗有诸如重复注射和不良反应等局限性.
- 对于底部神经血管疾病,需要新的治疗方法.
研究的目的:
- 开发一种新型的聚合物基因载体,用于基因和药物的联合输送.
- 创建一种用于抑制视网膜新血管化的双重治疗系统.
- 评估开发系统的 in vitro 和 in vivo 疗效.
主要方法:
- 开发了一种用酸修饰的线性聚乙烯胺 (LPEI-PBA) 基因载体.
- 制定了一种基因药物联合递送系统 (DPPV) 与甲酸 (DSP) 和pshVEGF.
- 在氧气诱导视网膜病变模型中测试DPPV的抗神经血管效应.
主要成果:
- 在体内,DPPV显著抑制了病理性新血管化的发生.
- DPPV下调的质激活标记物 (GFAP,IBA-1) 和IL-1β.
- DPPV提高了抗炎因子ARG-1的调节.
结论:
- DPPV纳米颗粒通过双重抗炎和抗血管生成有效抑制视网膜新血管化.
- 开发的系统显示承诺作为治疗方案的底部神经血管疾病.
- 单次内注射DPPV提供了一个潜在的改善的治疗策略.
相关概念视频
Drug Delivery: Miscellaneous Routes
716
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
716
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495


